April 2022
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference examined developments in Long Covid research and treatment following the updated NICE guidelines for managing its long-term effects.
Delegates discussed policy priorities for furthering clinical understanding, improving care provision, and supporting the health workforce.
It was also an opportunity to discuss the implementation of the NHS Long Covid plan for 2021/22, how best to utilise funding set out for the expansion of services, reducing variation, management of Long Covid within primary care, the future outlook for Long Covid research, and the impact of new NIHR-funded projects.
We are pleased to have been able to include keynote sessions with Professor Nick Lemoine, Chair, Long Covid Funding Committee and Medical Director, Clinical Research Network, NIHR; Dr Gail Allsopp, Clinical Lead for Clinical Policy, Royal College of General Practitioners; and Professor Brendan Delaney, Chair in Medical Informatics and Decision Making, Imperial College London.
Key areas for discussion included:
- the Long Covid Plan - delivery and the utilisation of allocated funding
- research - priority areas for further improving understanding of Long Covid and the effectiveness of services developed for the condition
- care pathways within ICS - leadership, implementation and commissioning, service development, rehabilitation, the impact of health inequalities, and integrating care
- Long Covid assessment clinics:
- assessing progress and what more is needed to improve accessibility and support referrals from primary care
- priorities for the development of services for children
- the health workforce - support, training and education priorities, and sharing best practice in Long Covid care
- data - scaling up its use and improving understanding of Long Covid and its prevalence
- involving patients - the development of Long Covid services, driving awareness of expanded online support, and improving accessibility of information
The conference was an opportunity for stakeholders to consider the issues alongside key policy officials who attended from the DHSC; the MHRA; OHID; ONS; the Prime Minister’s Office; UKHSA; the DWP; the Department of Health, NI; Defra; the DfT; DLUHC; the FCDO; HSE; HMRC; the NAO; The Scottish Government; and the Welsh Government - as well as parliamentary pass-holders from both Houses of Parliament and the Scottish Parliament.
